Sander Dubovy, MD; Professor of Ophthalmology and Pathology
Download (635.08 KB)
Sander R. Dubovy, M.D. is a Professor of Ophthalmology and Pathology and holds the Victor T. Curtin Chair of Ophthalmology at the Bascom Palmer Eye Institute (BPEI) of the University of Miami Miller School of Medicine. Board-certified both in ophthalmology and anatomic pathology, he serves as the medical director of the Florida Lions Eye Bank and Ocular Pathology Laboratory. Clinically, he cares for patients with diseases of the retina, macula and vitreous. He earned a Bachelor of Arts degree from the University of Virginia and a Medical degree from New York University School of Medicine. He completed an ophthalmology residency at the University of Chicago and a pathology residency at Columbia University. He served as an ophthalmic pathology fellow at the Wilmer Eye Institute of the Johns Hopkins University, served as a special fellow in ophthalmic pathology at the Armed Forces Institute of Pathology, and as medical retina at the Moorfields Eye Hospital/Institute of Ophthalmology in London. Dr. Dubovy is a member of the American Association of Ophthalmic Oncologists and Pathologists, the American Academy of Ophthalmology, the College of American Pathologists, United States and Canadian Academy of Pathology, the Florida Society of Ophthalmology, the Pan-American Association of Ophthalmology, the American Medical Association and the Florida Medical Association. Dr. Dubovy has received multiple teaching awards. He lectures and teaches ophthalmic pathology at universities throughout the country, has presented six named lectureships, served as visiting professor at 20 institutions, and has been an invited speaker at scientific meetings in over 20 foreign countries. He is the recipient of the Honor Award from the American Academy of Ophthalmology. His research interests include clinicopathologic correlation of ophthalmic disease entities, diagnostic ophthalmic pathology and treatments as well as macular diseases, including age-related macular degeneration and retinal occlusive disease.
There are no financial relationships to disclose.